SEC Form 4 · accession 0001140361-16-054449
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Serge Novovich
Director
Period of report
Feb 19, 2016
Accepted (ET)
Feb 22, 2016 · 7:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2016 | A | 6,563 | $1.48 | A | 107,546 | D | |
| Common StockF1 | Feb 19, 2016 | S | 2,910 | $17.2275 | D | 104,636 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.48 | Feb 19, 2016 | M | 6,563 | D | — | Dec 29, 2023 | Common Stock | 6,563 | 18,687 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $17.20 to $17.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This option, representing a right to purchase a total of 26,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.